The Asia Pacific patient portal market is expected to reach US$ 1,351.54 million by 2027 from US$ 305.2 million in 2019; it is estimated to grow at a CAGR of 20.0% from 2020 to 2027.
The market growth is attributed to key driving factors such as rising number of healthcare facilities adopting the patient portals and increasing demand for Electronic Health Record (EHR). Further, increasing use of cloud-based patient portal solutions would offer lucrative opportunities for the market during the forecast period. However, concerns regarding breach of privacy of patient records restrain the market growth.
The patient portal is a web-based solution connected with electronic health records and allows patients to access their health records. Governments worldwide are focusing on laying down the standards, regulations, and infrastructure for maintaining health records, which is increasing the demand for patient portals. Apart from this, increasing adoption of healthcare technologies by hospitals is driving the growth of the market. In March 2019, Huawei Technologies signed a partnership agreement with Guangdong Provincial People's Hospital for building a wireless healthcare hospital in China. Therefore, increasing adoption of the patient-centric approach and rising investment in healthcare IT infrastructure drive the Asia Pacific patient portal market.
The COVID-19 outbreak pandemic is adversely affecting countries in Asia Pacific. The use of patient portal in the management of COVID-19 treatment is becoming must in the region as the number of confirmed cases is continuously growing. Additionally, clinics and hospitals are cancelling or rescheduling the appointments of nonurgent treatments and are informing patients about the temporary policy. As a result, patients are increasingly using a patient portal to manage their clinical care, which is supporting the growth of the Asia Pacific patient portal market amid the pandemic.
The Asia Pacific patient portal market, by product, is bifurcated into standalone patient portals and integrated patient portals. The integrated patient portals segment held a larger share of the market in 2019, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.
The Asia Pacific patient portal market, by delivery mode, is bifurcated into web-based delivery and cloud-based delivery. The web-based delivery segment held a larger market share in 2019. However, the cloud-based delivery segment is anticipated to register a higher CAGR in the market during 2020–2027.
Based on end-user, the Asia Pacific patient portal market is segmented into providers, payers, pharmacies, and others. The providers segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources referred to while preparing the report on the Asia Pacific patient portal market are Korea Biomedicine Industry Association (KoBIA), China’s National Health Commission (NHM), and Organization for Economic Co-operation and Development (OECD).